Supplemental Data (Tables)

3 Months Ended

Mar. 31, 2018

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Condensed Consolidating Statements of Operations



	DaVita Inc.			Guarantor subsidiaries			Non- Guarantor subsidiaries			Consolidating adjustments			Consolidated total
For The Three Months Ended March 31, 2018	DaVita Inc.			Guarantor subsidiaries			Non- Guarantor subsidiaries			Consolidating adjustments			Consolidated total
Patient services revenues	$	—		$	1,790,188		$	848,401		$	(47,515	)	$	2,591,074
Provision for uncollectible accounts	—			9,628			15,917			—			25,545
Net patient service revenues	—			1,799,816			864,318			(47,515		)	2,616,619
Other revenues	195,565			204,960			70,933			(238,633		)	232,825
Total net revenues	195,565			2,004,776			935,251			(286,148		)	2,849,444
Operating expenses and charges	133,356			1,791,094			800,456			(286,148		)	2,438,758
Operating income	62,209			213,682			134,795			—			410,686
Debt expense	(114,334		)	(52,197		)	(7,375		)	60,390			(113,516		)
Other income, net	104,081			2,523			5,704			(107,726		)	4,582
Income tax expense	14,387			48,944			7,406			—			70,737
Equity earnings in subsidiaries	141,117			66,496			—			(207,613		)	—
Net income from continuing operations	178,686			181,560			125,718			(254,949		)	231,015
Net (loss) income from discontinued operations, net of tax	—			(40,443		)	(12,679		)	47,336			(5,786		)
Net income	178,686			141,117			113,039			(207,613		)	225,229
Less: Net income attributable to noncontrolling interests	—			—			—			(46,543		)	(46,543		)
Net income attributable to DaVita Inc.	$	178,686		$	141,117		$	113,039		$	(254,156	)	$	178,686



				Guarantor subsidiaries			Non- Guarantor subsidiaries			Consolidating adjustments			Consolidated total
For The Three Months Ended March 31, 2017	DaVita Inc.			Guarantor subsidiaries			Non- Guarantor subsidiaries			Consolidating adjustments			Consolidated total
Patient service revenues	$	—		$	1,530,726		$	929,231		$	(37,171	)	$	2,422,786
Provision for uncollectible accounts	—			(61,053		)	(46,005		)	—			(107,058		)
Net patient service revenues	—			1,469,673			883,226			(37,171		)	2,315,728
Other revenues	221,386			305,618			16,090			(227,571		)	315,523
Total net revenues	221,386			1,775,291			899,316			(264,742		)	2,631,251
Operating expenses	131,910			1,208,820			679,335			(264,742		)	1,755,323
Operating income	89,476			566,471			219,981			—			875,928
Debt expense	(102,664		)	(47,643		)	(12,232		)	58,142			(104,397		)
Other income	100,337			2,803			3,586			(102,740		)	3,986
Income tax expense	33,953			235,865			11,847			—			281,665
Equity earnings in subsidiaries	394,501			162,615			—			(557,116		)	—
Net income from continuing operations	447,697			448,381			199,488			(601,714		)	493,852
Net (loss) income from discontinued operations, net of tax	—			(53,880		)	15,715			44,598			6,433
Net income	447,697			394,501			215,203			(557,116		)	500,285
Less: Net income attributable to noncontrolling interests	—			—			—			(52,588		)	(52,588		)
Net income attributable to DaVita Inc.	$	447,697		$	394,501		$	215,203		$	(609,704	)	$	447,697

Condensed Consolidating Statements of Income



	Consolidated Total			Physician Groups			Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
For The Three Months Ended March 31, 2018	Consolidated Total			Physician Groups			Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
Patient service operating revenues	$	2,591,074		$	—		$	—	$	2,591,074
Provision for uncollectible accounts	25,545			—			—		25,545
Net patient service operating revenues	2,616,619			—			—		2,616,619
Other revenues	232,825			—			—		232,825
Total net operating revenues	2,849,444			—			—		2,849,444
Operating expenses	2,438,758			—			—		2,438,758
Operating income	410,686			—			—		410,686
Debt expense, including refinancing charges	(113,516		)	—			—		(113,516		)
Other income	4,582			—			—		4,582
Income tax expense	70,737			—			—		70,737
Net income from continuing operations	231,015			—			—		231,015
Net (loss) income from discontinued operations, net of tax	(5,786		)	7,397			490		(13,673		)
Net income	225,229			7,397			490		217,342
Less: Net income attributable to noncontrolling interests	(46,543		)	(6,543		)	—		(40,000		)
Net income attributable to DaVita Inc.	$	178,686		$	854		$	490	$	177,342


(1)	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Statements of Comprehensive Income



			Guarantor subsidiaries		Non- Guarantor subsidiaries		Consolidating adjustments			Consolidated total
For The Three Months Ended March 31, 2018	DaVita Inc.		Guarantor subsidiaries		Non- Guarantor subsidiaries		Consolidating adjustments			Consolidated total
Net income	$	178,686	$	141,117	$	113,039	$	(207,613	)	$	225,229
Other comprehensive income	2,587		—		19,881		—			22,468
Total comprehensive income	181,273		141,117		132,920		(207,613		)	247,697
Less: Comprehensive income attributable to noncontrolling interest	—		—		—		(46,543		)	(46,543		)
Comprehensive income attributable to DaVita Inc.	$	181,273	$	141,117	$	132,920	$	(254,156	)	$	201,154



				Guarantor subsidiaries		Non- Guarantor subsidiaries		Consolidating adjustments			Consolidated total
For The Three Months Ended March 31, 2017	DaVita Inc.			Guarantor subsidiaries		Non- Guarantor subsidiaries		Consolidating adjustments			Consolidated total
Net income	$	447,697		$	394,501	$	215,203	$	(557,116	)	$	500,285
Other comprehensive income	(506		)	—		13,261		—			12,755
Total comprehensive income	447,191			394,501		228,464		(557,116		)	513,040
Less: Comprehensive income attributable to the noncontrolling interests	—			—		—		(52,586		)	(52,586		)
Comprehensive income attributable to DaVita Inc.	$	447,191		$	394,501	$	228,464	$	(609,702	)	$	460,454

Condensed Consolidating Statements of Comprehensive Income



	Consolidated Total			Physician Groups			Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
For The Three Months Ended March 31, 2018	Consolidated Total			Physician Groups			Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
Net income	$	225,229		$	7,397		$	490	$	217,342
Other comprehensive income	22,468			—			—		22,468
Total comprehensive income	247,697			7,397			490		239,810
Less: Comprehensive income attributable to the noncontrolling interests	(46,543		)	(6,543		)	—		(40,000		)
Comprehensive income attributable to DaVita Inc.	$	201,154		$	854		$	490	$	199,810


(1)	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Balance Sheets



			Guarantor subsidiaries		Non- Guarantor subsidiaries		Consolidating adjustments			Consolidated total
As of March 31, 2018	DaVita Inc.		Guarantor subsidiaries		Non- Guarantor subsidiaries		Consolidating adjustments			Consolidated total
Cash and cash equivalents	$	122,047	$	—	$	236,827	$	—		$	358,874
Restricted cash and equivalents	1,003		9,421		78,320		—			88,744
Accounts receivable, net	—		1,257,461		573,129		—			1,830,590
Other current assets	35,555		368,131		267,396		—			671,082
Current assets held for sale	—		5,004,717		719,548		—			5,724,265
Total current assets	158,605		6,639,730		1,875,220		—			8,673,555
Property and equipment, net	413,949		1,554,591		1,216,683		—			3,185,223
Intangible assets, net	224		50,396		62,746		—			113,366
Investments in subsidiaries	10,180,619		3,138,371		—		(13,318,990		)	—
Intercompany receivables	3,593,688		—		1,488,211		(5,081,899		)	—
Other long-term assets and investments	54,952		58,467		218,217		—			331,636
Goodwill	—		4,730,205		1,908,387		—			6,638,592
Total assets	$	14,402,037	$	16,171,760	$	6,769,464	$	(18,400,889	)	$	18,942,372
Current liabilities	$	247,486	$	968,018	$	477,394	$	—		$	1,692,898
Current liabilities held for sale	—		759,020		495,605		—			1,254,625
Intercompany payables	—		3,589,494		1,492,405		(5,081,899		)	—
Long-term debt and other long-term liabilities	8,984,265		674,609		519,393		—			10,178,267
Noncontrolling interests subject to put provisions	589,606		—		—		444,895			1,034,501
Total DaVita Inc. shareholders' equity	4,580,680		10,180,619		3,138,371		(13,318,990		)	4,580,680
Noncontrolling interests not subject to put provisions	—		—		646,296		(444,895		)	201,401
Total equity	4,580,680		10,180,619		3,784,667		(13,763,885		)	4,782,081
Total liabilities and equity	$	14,402,037	$	16,171,760	$	6,769,464	$	(18,400,889	)	$	18,942,372



			Guarantor subsidiaries		Non- Guarantor subsidiaries		Consolidating adjustments			Consolidated total
As of December 31, 2017	DaVita Inc.		Guarantor subsidiaries		Non- Guarantor subsidiaries		Consolidating adjustments			Consolidated total
Cash and cash equivalents	$	149,305	$	—	$	358,929	$	—		$	508,234
Restricted cash and equivalents	1,002		9,384		300		—			10,686
Accounts receivable, net	—		1,208,715		506,035		—			1,714,750
Other current assets	67,025		595,066		86,955		—			749,046
Current assets held for sale	—		4,992,067		769,575		—			5,761,642
Total current assets	217,332		6,805,232		1,721,794		—			8,744,358
Property and equipment, net	408,010		1,560,390		1,180,813		—			3,149,213
Intangible assets, net	250		50,971		62,606		—			113,827
Investments in subsidiaries	10,009,874		3,085,722		—		(13,095,596		)	—
Intercompany receivables	3,677,947		—		1,313,213		(4,991,160		)	—
Other long-term assets and investments	47,297		68,344		214,875		—			330,516
Goodwill	—		4,732,320		1,877,959		—			6,610,279
Total assets	$	14,360,710	$	16,302,979	$	6,371,260	$	(18,086,756	)	$	18,948,193
Current liabilities	$	238,706	$	1,181,139	$	436,262	$	—		$	1,856,107
Current liabilities held for sale	—		739,294		445,776		—			1,185,070
Intercompany payables	—		3,690,042		1,301,118		(4,991,160		)	—
Long-term debt and other long-term liabilities	8,857,373		682,630		469,587		—			10,009,590
Noncontrolling interests subject to put provisions	574,602		—		—		436,758			1,011,360
Total DaVita Inc. shareholders' equity	4,690,029		10,009,874		3,085,722		(13,095,596		)	4,690,029
Noncontrolling interests not subject to put provisions	—		—		632,795		(436,758		)	196,037
Total equity	4,690,029		10,009,874		3,718,517		(13,532,354		)	4,886,066
Total liabilities and equity	$	14,360,710	$	16,302,979	$	6,371,260	$	(18,086,756	)	$	18,948,193

Condensed Consolidating Balance Sheets



	Consolidated Total		Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
As of March 31, 2018	Consolidated Total		Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
Cash and cash equivalents	$	358,874	$	—	$	—	$	358,874
Restricted cash and equivalents	88,744		—		—		88,744
Accounts receivable, net	1,830,590		—		—		1,830,590
Other current assets	671,082		133,199		—		537,883
Current assets held for sale	5,724,265		319,968		3,223		5,401,074
Total current assets	8,673,555		453,167		3,223		8,217,165
Property and equipment, net	3,185,223		—		—		3,185,223
Amortizable intangibles, net	113,366		—		—		113,366
Other long-term assets	331,636		—		—		331,636
Goodwill	6,638,592		—		—		6,638,592
Total assets	$	18,942,372	$	453,167	$	3,223	$	18,485,982
Current liabilities	$	1,692,898	$	—	$	—	$	1,692,898
Current liabilities held for sale	1,254,625		328,493		—		926,132
Payables to parent	—		—		3,223		(3,223		)
Long-term debt and other long-term liabilities	10,178,267		—		—		10,178,267
Noncontrolling interests subject to put provisions	1,034,501		—		—		1,034,501
Total DaVita Inc. shareholders’ equity	4,580,680		124,674		—		4,456,006
Noncontrolling interests not subject to put provisions	201,401		—		—		201,401
Shareholders’ equity	4,782,081		124,674		—		4,657,407
Total liabilities and shareholder’s equity	$	18,942,372	$	453,167	$	3,223	$	18,485,982


(1)	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Statements of Cash Flows



				Guarantor subsidiaries			Non- Guarantor subsidiaries			Consolidating adjustments			Consolidated total
For The Three Months Ended March 31, 2018	DaVita Inc.			Guarantor subsidiaries			Non- Guarantor subsidiaries			Consolidating adjustments			Consolidated total
Cash flows from operating activities:
Net income	$	178,686		$	141,117		$	113,039		$	(207,613	)	$	225,229
Changes in operating assets and liabilities and non-cash items included in net income	(82,391		)	32,484			(20,396		)	207,613			137,310
Net cash provided by operating activities	96,295			173,601			92,643			—			362,539
Cash flows from investing activities:
Additions of property and equipment	(27,356		)	(125,375		)	(79,712		)	—			(232,443		)
Acquisitions	—			(4,417		)	(12,165		)	—			(16,582		)
Proceeds from asset and business sales	—			18,535			—			—			18,535
Proceeds (purchases) from investment sales and other items, net	31,665			(762		)	(541		)	—			30,362
Net cash provided by (used in) investing activities	4,309			(112,019		)	(92,418		)	—			(200,128		)
Cash flows from financing activities:
Long-term debt and related financing costs, net	116,307			(3,377		)	(8,257		)	—			104,673
Intercompany borrowing (payments)	47,394			(49,783		)	2,389			—			—
Other items	(291,562		)	(2,200		)	(33,458		)	—			(327,220		)
Net cash used in financing activities	(127,861		)	(55,360		)	(39,326		)	—			(222,547		)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	—			—			6,668			—			6,668
Net (decrease) increase in cash, cash equivalents and restricted cash	(27,257		)	6,222			(32,433		)	—			(53,468		)
Less: Net increase in cash, cash equivalents and restricted cash from discontinued operations	—			6,185			11,649			—			17,834
Net (decrease) increase in cash, cash equivalents and restricted cash from continuing operations	(27,257		)	37			(44,082		)	—			(71,302		)
Cash, cash equivalents and restricted cash of continuing operations at beginning of the year	150,307			9,384			359,229			—			518,920
Cash, cash equivalents and restricted cash of continuing operations at end of the period	$	123,050		$	9,421		$	315,147		$	—		$	447,618



				Guarantor subsidiaries			Non- Guarantor subsidiaries			Consolidating adjustments			Consolidated total
For The Three Months Ended March 31, 2017	DaVita Inc.			Guarantor subsidiaries			Non- Guarantor subsidiaries			Consolidating adjustments			Consolidated total
Cash flows from operating activities:
Net income	$	447,697		$	394,501		$	215,203		$	(557,116	)	$	500,285
Changes in operating assets and liabilities and non-cash items included in net income	(149,627		)	(142,597		)	99,994			557,116			364,886
Net cash provided by operating activities	298,070			251,904			315,197			—			865,171
Cash flows from investing activities:
Additions of property and equipment	(30,580		)	(133,909		)	(50,046		)	—			(214,535		)
Acquisitions	—			(70,237		)	(6,999		)	—			(77,236		)
Proceeds from asset and business sales, net of cash divested	—			46,612			—			—			46,612
(Purchases) proceeds from investment sales and other items, net	(54,150		)	(1,951		)	51,273			—			(4,828		)
Net cash used in investing activities	(84,730		)	(159,485		)	(5,772		)	—			(249,987		)
Cash flows from financing activities:
Long-term debt and related financing costs, net	(27,504		)	(4,616		)	(4,021		)	—			(36,141		)
Intercompany borrowing (payments)	338,984			(71,541		)	(267,443		)	—			—
Other items	3,330			(799		)	(25,327		)	—			(22,796		)
Net cash used in financing activities	314,810			(76,956		)	(296,791		)	—			(58,937		)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	—			—			2,820			—			2,820
Net increase in cash, cash equivalents and restricted cash	528,150			15,463			15,454			—			559,067
Less: Net increase in cash, cash equivalents and restricted cash from discontinued operations	—			15,438			9,055			—			24,493
Net increase in cash, cash equivalents and restricted cash from continuing operations	528,150			25			6,399						534,574
Cash, cash equivalents and restricted cash of continuing operations at beginning of the year	549,921			8,687			124,855			—			683,463
Cash, cash equivalents and restricted cash of continuing operations at end of the period	$	1,078,071		$	8,712		$	131,254					$	1,218,037

Condensed Consolidating Statements of Cash Flows



	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
For The Three Months Ended March 31, 2018	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
Cash flows from operating activities:
Net income	$	225,229		$	7,397		$	490		$	217,342
Changes in operating and intercompany assets and liabilities and non-cash items included in net income	137,310			(20,189		)	(490		)	157,989
Net cash provided by (used in) operating activities	362,539			(12,792		)	—			375,331
Cash flows from investing activities:
Additions of property and equipment	(232,443		)	(1,165		)	—			(231,278		)
Acquisitions	(16,582		)	—			—			(16,582		)
Proceeds from asset and business sales	18,535			—			—			18,535
Investments and other items	30,362			(541		)	—			30,903
Net cash used in investing activities	(200,128		)	(1,706		)	—			(198,422		)
Cash flows from financing activities:
Long-term debt	104,673			—			—			104,673
Intercompany	—			1,082			—			(1,082		)
Other items	(327,220		)	—			—			(327,220		)
Net cash (used in) provided by financing activities	(222,547		)	1,082			—			(223,629		)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	6,668			—			—			6,668
Net decrease in cash, cash equivalents and restricted cash	(53,468		)	(13,416		)	—			(40,052		)
Less: Net increase (decrease) in cash, cash equivalents and restricted cash from discontinued operations	17,834			(13,416		)	—			31,250
Net decrease in cash, cash equivalents and restricted cash from continuing operations	(71,302		)	—			—			(71,302		)
Cash, cash equivalents and restricted cash of continuing operations at beginning of the year	518,920			—			—			518,920
Cash, cash equivalents and restricted cash of continuing operations at end of the period	$	447,618		$	—		$	—		$	447,618


(1)	After elimination of the unrestricted subsidiaries and the physician groups.